Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Daily deal net: August 7, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Taysha takes $95m in series B…

The CNS disease drug developer has raised funding in a GV-backed round just four months after it emerged from UT Southwestern with $30m.

Osage University Partners backed a round for Aerovate Therapeutics that will go to testing an inhaled version of the latter’s pulmonary disease therapy.


GCV Digital Forum 2020
29th September 2020
GCV Symposium 2020
7th December 2020
StreetLight Data cruises into $15m series D
Osage University Partners has returned to bring the big urban transit data analytics company's funding total to $36.1m.
Censys seizes $15.5m series A
GV and Decibel co-led the round having previously backed the U-M networking cybersecurity company alongside Greylock Partners in 2016.
Wenge Tech garners $28.7m series C
Wenge Tech, a CAS-owned data analytics business targeting media applications, has attracted Cash Holdings and CAS Star for its latest round.
Ginger gives zest to series D
Cigna and Kaiser Permanente have participated in a $50m series D round for Ginger, bringing the MIT spinout's total funding to more than $120m.
Freeline forges ahead with $159m IPO
UCL's Freeline Therapeutics has priced its shares at $18 to raise nearly $159m through an IPO on the Nasdaq Global Select Market.
DeepX dives for $15m
Fujita, Industrial Growth Platform and SBI were among the investors in the automation technology developer, a spinout of University of Tokyo.
test reg